Caplin Point Laboratories Limited will host a post-results conference call on August 12, 2026, at 4:30 PM IST to discuss its financial performance for the quarter ended June 30, 2026. The announcement, filed under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, provides investors and analysts with an opportunity to review the company's Q1 FY27 results. The schedule is subject to change due to exigencies on the part of the analysts or the company.

Conference Call Details

The conference call aims to provide clarity on the financial metrics and operational updates for the period. Management will address queries from fund houses, analysts, and investors regarding the quarterly performance. Pre-registration is recommended to avoid waiting queues, with access provided via a DiamondPass link.

Participating Executives

The following senior leadership team members are scheduled to represent the company during the call:

Dial-In Information

Participants can join the conference using the universal access numbers or international toll-free lines listed below:

Investor Relations Contact

For further information regarding the earnings call or financial data, investors may contact the research team at Dolat Capital Market Pvt. Ltd., which serves as the investor relations advisor:

• Rashmi Shetty, Director - Research: +91 22 40969724
• Candice Pereira, AVP Research: +91 22 61764873
• Zain Gulam Hussain, Associate: +91 22 40969790

The notice was issued by Venkatram G, General Counsel & Company Secretary, on July 30, 2026.

Caplin Point Laboratories Ltd has disclosed that no encumbrance was created on its shares during the financial year ended March 31, 2026. The declaration, submitted by the promoter and promoter group, confirms that no shares were encumbered directly or indirectly throughout FY26. This disclosure provides shareholders with assurance regarding the unencumbered status of the promoter holdings during the period.

The filing was made pursuant to Regulation 31(4) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. The declaration was submitted on behalf of several entities and individuals associated with the company's promoter group.

The following table details the entities and individuals on whose behalf the declaration was submitted:

The declaration was signed by Partheeban Vivek Siddarth, Vice Chairman and Director, on April 06, 2026. A copy of the declaration was forwarded to the Audit Committee of Caplin Point Laboratories Limited.